Pioneering gastrointestinal disease diagnostics, monitoring, and management.

Origin is advancing the field through the development of OriCol™, a unique rectal mucus collection device that enables powerful new insights from an underexplored specimen type.

Our current focus is on addressing the urgent need for accurate, affordable in-vitro diagnostics for colorectal cancer and advanced adenomas. At the same time, our team is actively expanding the potential of OriCol™ into other critical areas of unmet clinical need, including:

  • Aero-digestive cancers and disease
  • Inflammatory bowel disease (diagnostics and monitoring)

By unlocking the diagnostic potential of rectal mucus, Origin is helping to transform early detection, disease management, and patient outcomes worldwide.